113 related articles for article (PubMed ID: 38639732)
1. Prognostic value of triglyceride-glucose index for left ventricular remodeling in nondiabetic ST-elevation myocardial infarction patients.
Efe TH; Algül E
Biomark Med; 2024; 18(6):243-252. PubMed ID: 38639732
[TBL] [Abstract][Full Text] [Related]
2. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
3. Association between TyG index and long-term prognosis of patients with ST-segment elevated myocardial infarction undergoing percutaneous coronary intervention: a retrospective cohort study.
Zeng D; Wang K; Chen Z; Yao C
BMJ Open; 2024 Jun; 14(6):e079279. PubMed ID: 38889947
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.
Rokicka D; Hudzik B; Wróbel M; Stołtny T; Stołtny D; Nowowiejska-Wiewióra A; Rokicka S; Gąsior M; Strojek K
Cardiovasc Diabetol; 2024 Apr; 23(1):147. PubMed ID: 38685054
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
[TBL] [Abstract][Full Text] [Related]
7. Risk Prediction Model Based on Biomarkers of Remodeling in Patients with Acute Anterior ST-Segment Elevation Myocardial Infarction.
Liu Z; Liu L; Cheng J; Zhang H
Med Sci Monit; 2021 Jul; 27():e927404. PubMed ID: 34282109
[TBL] [Abstract][Full Text] [Related]
8. Reverse Left Ventricular Remodelling in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: Incidence, Predictors, and Impact on Outcome.
Choe JC; Cha KS; Yun EY; Ahn J; Park JS; Lee HW; Oh JH; Kim JS; Choi JH; Park YH; Lee HC; Kim JH; Chun KJ; Hong TJ; Ahn Y; Jeong MH; Chae SC; Kim YJ;
Heart Lung Circ; 2018 Feb; 27(2):154-164. PubMed ID: 28487063
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
Wang L; Wang Y; Wang W; Wang Z
Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
[TBL] [Abstract][Full Text] [Related]
12. Value of speckle-tracking echocardiography for prediction of left ventricular remodeling in patients with ST-elevation myocardial infarction treated by primary percutaneous intervention.
Bochenek T; Wita K; Tabor Z; Grabka M; Krzych Ł; Wróbel W; Berger-Kucza A; Elżbieciak M; Doruchowska A; Gluza MT
J Am Soc Echocardiogr; 2011 Dec; 24(12):1342-8. PubMed ID: 22000785
[TBL] [Abstract][Full Text] [Related]
13. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction.
Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2351-2362. PubMed ID: 32917496
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical outcomes and left ventricular remodeling after ST-elevation myocardial infarction between patients with and without diabetes mellitus.
Akashi N; Tsukui T; Yamamoto K; Seguchi M; Taniguchi Y; Sakakura K; Wada H; Momomura SI; Fujita H
Heart Vessels; 2021 Oct; 36(10):1445-1456. PubMed ID: 33715109
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Speckle Tracking Echocardiography in Patients with ST-Elevation Myocardial Infarction Treated with Late Percutaneous Intervention.
Cong T; Sun Y; Shang Z; Wang K; Su D; Zhong L; Zhang S; Yang Y
Echocardiography; 2015 Sep; 32(9):1384-91. PubMed ID: 25471825
[TBL] [Abstract][Full Text] [Related]
16. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
[TBL] [Abstract][Full Text] [Related]
17. Association Between Segmental Noninvasive Myocardial Work and Microvascular Perfusion in ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Functional Recovery and Clinical Outcomes.
Sun S; Chen N; Sun Q; Wei H; Fu T; Shang Z; Sun Y; Cong T; Xia Y; Xie F; Porter TR
J Am Soc Echocardiogr; 2023 Oct; 36(10):1055-1063. PubMed ID: 37225007
[TBL] [Abstract][Full Text] [Related]
18. Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction.
Tona F; Civieri G; Vadori M; Masiero G; Iop L; Marra MP; Perin V; Cuciz E; Cecere A; Bernava G; Tansella D; Naumova N; Grewal S; Cozzi E; Iliceto S
J Am Heart Assoc; 2024 Feb; 13(4):e032672. PubMed ID: 38348777
[TBL] [Abstract][Full Text] [Related]
19. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Park Y; Tantry US; Koh JS; Ahn JH; Kang MG; Kim KH; Jang JY; Park HW; Park JR; Hwang SJ; Park KS; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
Thromb Haemost; 2017 May; 117(5):911-922. PubMed ID: 28150852
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
